The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Inter Partes Reviews of Pharmaceutical Patents: Understanding How IPRs are Changing the Landscape of Innovator/Generic Litigation" on July 23, 2014 beginning at 2:00 pm (ET). Paul Golian of Bristol-Myers Squibb Co. will moderate a panel consisting of Aaron Barkoff of McAndrews, Held & Malloy, Ltd.; Grantland Drutchas of McDonnell Boehnen Hulbert & Berghoff LLP; and Michael Fuller of Knobbe, Martens, Olson and Bear, L.L.P, which will focus on the rapidly increasing use of IPRs to invalidate pharmaceutical patents in ANDA litigation. The panel will give an overview of the IPR process and timelines, discuss the outcomes of recent IPR challenges in the pharmaceutical space, and present tips and strategies for both challenging pharmaceutical patents and defending against such challenges.
The registration fee for the webinar is $130 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.
Comments